GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months. The company says new ...

Add Yahoo as a preferred source to see more of our stories on Google. Nearly two years after breaking ground, the Catawba Two Kings Casino is taking shape off Interstate 85, about 35 miles from ...

AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...

Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

Yarilet Perez is an experienced multimedia journalist and fact-checker with a Master of Science in Journalism. She has worked in multiple cities covering breaking news, politics, education, and more.

IOD distinguishes itself as scientific home for researchers working at the boundaries of traditional academic spheres, and generating growing programs in the integration of research with informatics ...